目的探讨共刺激分子B7 1 (CD80)在血液系统恶性肿瘤发病学及免疫基因治疗中的重要作用。
Objective to explore the significance of costimulatory molecule B7-1 (CD80) and MHC molecules in the pathogenesis of hematologic malignant tumors and in the immuno-genetic therapy.
结论肾恶性肿瘤患者存在血液流变学指标的异常。
Conclusion the hemorheological parameters in patient with kidney malignant tumor exist the abnormality.
前言：目的：了解老年恶性肿瘤患者血液流变学及血小板的变化。
Objective: To study the changes of hemorheology and blood platelets in elderly patients with malignant tumors.
结果：老年恶性肿瘤患者血液流变学参数及血小板计数均明显高于健康老年人。
Results: Hemorheology and the number of platelets of elder patients with malignant tumors obviously exceeded that of healthy elderly people.
医师教育资源(人事)是继续医学教育公司在肿瘤学和血液学专业。
Physicians' education Resource (PER) is a continuing medical education company specializing in oncology and hematology.
目的探索大肠恶性肿瘤血液流变学及血脂水平变化的规律，评价其临床意义。
Objective the change of hemorheological parameters and lipid metabolism in patients with large bowel malignancies was studied to explore their clinical value.
从细胞生物学及分子生物学水平，立足于中药对机体免疫功能、对血管血液系统、对癌前病变的影响及有关方面探讨了中药抗恶性肿瘤的有关机理。
This paper deals with the mechanisms of the treatment with reference to cytobiology and molecular biology and the effect of Chinese medicine on immunity, the blood system and pathological changes.
目的比较良恶性肿瘤患者的血液流变学及血凝的变化。
Objective To compare the changes of hemorheology and blood concretion status in patients with benign and malignant tumors.
入院接受密集化疗的血液学恶性肿瘤的病人被随机分为两组，在单中心实验中用双盲法处理安慰剂组和控制组。
Patients with haematological malignancies receiving intensive chemotherapy and requiring hospitalization were randomized in a double-blind, placebo-controlled single-centre trial.
入院接受密集化疗的血液学恶性肿瘤的病人被随机分为两组，在单中心实验中用双盲法处理安慰剂组和控制组。
Patients with haematological malignancies receiving intensive chemotherapy and requiring hospitalization were randomized in a double-blind, placebo-controlled single-centre trial.
应用推荐